RxDoctor Payments DataLook up a doctor →

Anna Castro

Family · San Antonio, TXNPI 1841744315

Payments from drug & device makers

$183,975in general payments, 2019–2025

Across 1,117 payments — averaging $164.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$118K
  • Lundbeck LLC$25K
  • Impel Pharmaceuticals Inc.$13K
  • Axsome Therapeutics, Inc.$9K
  • Biogen$7K
  • Teva Pharmaceuticals USA, Inc.$2K
  • plus $10K from 42 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)376$117,771
Lundbeck LLC92$24,969
Impel Pharmaceuticals Inc.44$12,897
Axsome Therapeutics, Inc.24$8,887
Biogen18$7,174
Teva Pharmaceuticals USA, Inc.181$2,479
EMD Serono, Inc.20$2,284
Bristol Myers Squibb7$1,338
Pfizer91$1,244
Amgen(2 entities)37$1,108
Novartis40$508
Lilly USA, LLC26$493
Biohaven Pharmaceutical Holding Company Ltd.25$217
Biohaven Pharmaceuticals, Inc.6$176
Mallinckrodt Hospital Products Inc.6$159
Upsher-smith Laboratories LLC7$156
Merz Pharmaceuticals, LLC6$150
Genentech USA, Inc.6$143
UCB, Inc.6$141
Johnson & Johnson6$129
Sunovion Pharmaceuticals Inc.15$123
Amneal Pharmaceuticals LLC8$111
SK Life Science, Inc.5$102
Kyowa Kirin, Inc.4$101
Avanir Pharmaceuticals, Inc.5$92
Eisai Inc.4$89
Acadia Pharmaceuticals Inc5$89
Abbott5$85
MDD US Operations, LLC5$84
Supernus Pharmaceuticals, Inc.4$78
Neurocrine Biosciences, Inc.3$73
Impel Pharmaceuticals LLC4$71
Sanofi4$65
Tonix Medicines, Inc.2$49
Scilex Pharmaceuticals Inc.3$45
CSL Behring3$42
E.r. Squibb & Sons, L.L.C.2$38
Acorda Therapeutics, Inc1$29
GE HealthCare2$28
Boston Scientific1$26
Adamas Pharmaceuticals, Inc.1$21
Sanofi-aventis U.S. LLC1$20
GRT US Holding, Inc.1$19
Almatica Pharma LLC1$18
Collegium Pharmaceutical, Inc.1$16
Cycle Pharmaceuticals Inc1$15
Arbor Pharmaceuticals, Inc.1$14
Sumitomo Pharma America, Inc.1$13

How this compares

$183,975 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Medicare billing

Part B allowed, 2024
$25,303
Medicare patients
77
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →